Entities / Entity
Fate Therapeutics.
a clinical-stage biopharmaceutical company in San Diego, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Fate Therapeutics this week
News at the entities that move Fate Therapeutics most-
FDA StructuralFDA granted approvals for RASONQUE and WELTRUZA on November 4, 2026.Moves Fate Therapeutics
-
Nasdaq StructuralAnika Wells defended the social media ban law while Nvidia's rebound lifted the Nasdaq composite on November 4, 2026.Moves Fate Therapeutics
-
Jefferies Financial Group Mentioned togetherMorgan Stanley and ODDO BHF downgraded Vonovia, while Jefferies Financial Group maintained a buy rating on the European real estate company.Moves Fate Therapeutics
-
San Diego Shared contextCollaboration announced between PHARM in San Diego and Menlo Park.Moves Fate Therapeutics
Connections
The 4 strongest of 14, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Fate Therapeutics relies on the FDA for evaluation and accelerated market pathway support.
-
Nasdaq Structural
Fate Therapeutics is a publicly listed company that operates and trades on the Nasdaq exchange.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides market coverage and price targets for Fate Therapeutics stock.
-
San Diego Shared context
Fate Therapeutics is based in San Diego and conducts its operations from that location.